ImmunoGen, Inc. is focused on the development of antibody-based anticancer therapeutics. The Company’s Tumor-Activated Prodrug (TAP) technology uses antibodies
More$10 mil. - $25 mil.in Revenue
100 - 250Employees
Contact people at this companytargeted anticancer therapeuticsbiopharmaceuticaltargeted anticancer products
More
830 Winter StWalthamMassachusetts02451United States
view map(781) 895-0600(781) 895-0611Fax
Russell 3000
Pro2013_Iteration8.31[03] SEIDXWK-21